CTX: Net loss widened on lower R&D revenue, but equity strengthened after a major share issue

Revenue from R&D services declined sharply year-over-year, while net loss widened due to higher R&D costs. A major share issue in March 2026 strengthened equity and liquidity, and management expects sufficient resources for at least 12 months, with ongoing partnership talks and grant funding pursue…